---
schema_version: "secwatch.filing_event.v1"
accession: "0000897101-24-000069"
form_type: "8-K"
ticker: "ELMD"
cik: "0001488917"
company_name: "Electromed, Inc."
filed_at: "2024-02-13T23:59:59+00:00"
generated_at: "2026-06-06T03:20:33.600926+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Electromed Q2 FY2024 revenue record $13.7M (+17% YoY), EPS $0.19 vs $0.11

## Summary
- Net revenue increased 17% to record $13.7M; direct homecare revenue up 18% to $12.7M.
- Gross margins improved to 77% from 74%; operating income record $2.263M (16.5% of revenue).
- Diluted EPS $0.19 vs $0.11; net income record $1.674M.
- Cash $10.4M, no debt; annualized homecare revenue per rep $1,007,000 above target range.
- Field sales force totaled 58, with 49 direct sales representatives.

## SEC filing metadata
- accession: 0000897101-24-000069
- form_type: 8-K
- ticker: ELMD
- cik: 0001488917
- company_name: Electromed, Inc.
- filed_at: 2024-02-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1488917/000089710124000069/0000897101-24-000069-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1488917/000089710124000069/elmd240161_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000897101-24-000069
- JSON: https://secwatch.observer/filing/0000897101-24-000069.json
- Plain text: https://secwatch.observer/filing/0000897101-24-000069.txt

## Key facts
- Earnings Releases
  Electromed, Inc. reported Q2 FY 2024 results: revenue $13.7 million, net income $1,674,000, EPS $0.19 per diluted share.
  - Period: Q2 FY 2024
  - Revenue: $13.7 million
  - Net income: $1,674,000
  - EPS: $0.19 per diluted share
  - Result: reported results
  source text: Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2023 (“Q2 FY 2024”). Q2 FY 2024 Financial Highlights ● Net revenue increased 17% to a record $13.7 million in Q2 FY 2024, from $11.7 million in the second quarter of the prior fiscal year. ● Gross margins were 77% of revenue, compared to 74% in the second quarter of the prior fiscal year. ● Operating income was a record $2,263,000 or 16.5% of revenue, compared with $1,274,000 or 10.9% of revenue in the second quarter of the prior fiscal year. ● Net income was a record $1,674,000 for the quarter, or $0.19 per diluted share, compared to $977,000, or $0.11 per diluted share in the second quarter of the prior fiscal year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1488917/000089710124000069/0000897101-24-000069-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.